100% import substitution is impossible in Russian pharmaceutical industry, says trade group

At the XIV Interregional forum ‘Healthcare and resort medicine,’ which started on April 25 in Yessentuki, Russia, there was a Medicines Import substitution round-table discussion.

Viktor Dmitriev, chief executive of the Association of Russian Pharmaceutical Manufactures (ARPM), as the moderator spoke about the issues of medical import substitution and quality control in producing Russian medicines.

He stated that 100% import substitution in a pharmaceutical industry is impossible because of the absence of Russian equipment facilities which match with modern standards. Even those companies which talk about the full-cycle of medicines manufacturing use import equipment. Unfortunately, we will be technologically dependent for a long time, he pointed out.